...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith AGM Corporation Update Slides and Webcast

Agreed Narmac,

it also restricts our ability to transfer our shares to registered accounts to shelter from the tax man if we have a winner down the road.

Share
New Message
Please login to post a reply